How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Neuro-linguistic programming (NLP) is a set of principles and techniques aimed at enhancing self-awareness, increasing confidence, building communication skills, and motivating positive social actions ...

Range anxiety has haunted EV buyers since Tesla’s first Roadster, turning every road trip into a charging station treasure hunt. Factorial Energy and Karma Automotive just announced the cure: ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Somer G. Anderson is CPA, doctor of ...